Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Brimonidine/brinzolamide (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 28 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 28 Apr 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 05 Nov 2013 New trial record